Neurocrine Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $2.07B
Liabilities Breakdown FY2021
Total Liabilities: $698.5M
Asset Breakdown
Total Assets: $2.07B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $340.8M | 16.4% |
| Accounts Receivable | $185.5M | 9.0% |
| Inventory | $30.5M | 1.5% |
| Property, Plant & Equipment | $58.6M | 2.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.46B | 70.3% |
Liabilities Breakdown
Total Liabilities: $698.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $698.5M | 100.0% |